Recursion Pharmaceuticals Azioni (NASDAQ: RXRX)

Recursion Pharmaceuticals (NASDAQ:RXRX) Azioni

Recursion Pharmaceuticals

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Fiserv,Office,In,Brookfield,,Wisconsin,,Usa,-,May,3,,2023.

News

Markets

Media

Trading Ideas

First Trust Advantage Preferred Income Fund

RGTI

RXRX

SMCI

&#34;Mad Money&#34;: quali azioni premiare e quali scartare secondo l&#39;esperto di Wall Street? Una bussola per orientarsi tra le sue valutazioni.

Jim Cramer svela le sue scelte: 2 titoli da comprare subito e 1 da evitare

Recursion Pharmaceuticals, Inc. - Class A Common Stock

Recursion Pharmaceuticals Inc

Truist Securities analyst Lucas Servera initiates coverage on ArcBest (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCB#NASDAQ">ARCB</a>) with a Buy rating and announces Price Target of $93.

Price Target

Initiation

Analyst Ratings

ARCB

Truist Securities Initiates Coverage On ArcBest with Buy Rating, Announces Price Target of $93

Guidance

DLTH

Duluth Sees FY25 Revenue Of $570M - $595M Vs. $642.433M Est.

Duluth Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTH#NASDAQ">DLTH</a>) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $0.11 by 136.36 percent. This is a 119.05 percent decrease over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $241.27 million which missed the analyst consensus estimate of $252.86 million by 4.58 percent. This is a 1.77 percent decrease over sales of $245.61 million the same period last year.

Earnings

Earnings Misses

Duluth Holdings Q4 Adj $(0.04) Misses $0.11 Estimate, Sales $241.27M Miss $252.86M Estimate

The Board is undertaking a search for Sato's replacement. The Board of Directors has appointed Schlecht as Interim Chief Executive Officer, effective&nbsp;April 25, 2025, unless the Board concludes its CEO search before that date.

Management

Duluth Reports Retirement Of CEO Samuel M. Sato; Stephen Schlecht To Assume Day-to-Day Leadership

Truist Securities analyst Lucas Servera initiates coverage on C.H. Robinson Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRW#NASDAQ">CHRW</a>) with a Buy rating and announces Price Target of $115.

CHRW

Truist Securities Initiates Coverage On C.H. Robinson Worldwide with Buy Rating, Announces Price Target of $115

Truist Securities analyst Lucas Servera initiates coverage on FedEx (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) with a Buy rating and announces Price Target of $305.

Truist Securities Initiates Coverage On FedEx with Buy Rating, Announces Price Target of $305

Hannover Rueck (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HVRRY#OTC">HVRRY</a>) reported quarterly earnings of $4.46 per share. This is a 77.69 percent increase over earnings of $2.51 per share from the same period last year. The company reported $7.13 billion in sales this quarter. This is a 1.66 percent decrease over sales of $7.25 billion the same period last year.

Hannover Ruckversicherungs Registered shares 

HVRRY

Hannover Rueck Q4 EPS $4.46 Up From $2.51 YoY, Sales $7.13B Down From $7.25B YoY

Keefe, Bruyette &amp; Woods analyst MarK Shutley initiates coverage on Eagle Financial Services (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EFSI#NASDAQ">EFSI</a>) with a Outperform rating and announces Price Target of $40.

EFSI

Keefe, Bruyette & Woods Initiates Coverage On Eagle Financial Services with Outperform Rating, Announces Price Target of $40

A renowned Argentine lawyer has officially called for the international arrest of the cryptocurrency entrepreneur allegedly involved in the LIBRA token scandal.
What Happened: Gregorio Dalbon, who previously&nbsp;represented former Argentine President Cristina&nbsp;Fernandez in a corruption case, filed a formal request for an Interpol Red Notice for&nbsp;Hayden Davis, CEO of Kelsier Ventures and advisor to President Javier Milei, who helped launch the scam-tainted token, according to Argentine media outlet Perfil. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Caso <a href="https://twitter.com/search?q=%24LIBRA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$LIBRA</a>: pidieron la detención inmediata de Hayden Davis &#x7C; Perfil <a href="https://t.co/xa4mV8Rja2">https://t.co/xa4mV8Rja2</a>
&mdash; Gregorio Dalbon (@Gregoriodalbon) <a href="https://twitter.com/Gregoriodalbon/status/1899549500135419983?ref_src=twsrc%5Etfw">March 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Dalbon submitted the petition&nbsp;to lead prosecutor Eduardo Taiano&nbsp;and Judge María Servini on Tuesday, seeking&nbsp;an Interpol Red Notice to&nbsp;expedite Davis&#8217;s&nbsp;detention and extradition from the&nbsp;U.S.
Dalbon argued that Davis might impede the case&#8217;s progress by fleeing his home country, the U.S., or by remaining in hiding.
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/25/03/44267582/us-house-committee-favors-stablecoin-regulation-to-strenthen-dollar-advocates-against-cbdc">House Committee Favors Stablecoin Regulation To &#8216;Strengthen&#8217; Dollar: Majority Whip Says CBDCs Against &#8216;American Values&#8217;</a>
Why It Matters: This move marked a significant&nbsp;escalation in the legal proceedings&nbsp;surrounding a case that has&nbsp;embroiled Milei&#8217;s administration in controversy. 
The president had<a href="https://in.benzinga.com/25/02/43769603/argentinas-stock-market-plummets-amid-milei-meme-coin-controversy"> publicly endorsed</a>&nbsp;the LIBRA shortly before its&nbsp;dramatic collapse, triggering allegations of a rug pull—a scam where creators accumulate funds for a project, causing its value to soar only to disappear with the invested funds, leaving the project worthless.
The Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)-based coin ran up to over $170 million in market capitalization after launch but has since lost 92% of its value.
Davis had denied the <a href="https://in.benzinga.com/25/02/43786713/solana-meme-coin-ecosystem-under-fire-galaxy-research-cites-libra-rug-pull-as-major-blow">allegations of a rug pull</a>, saying, "It's just a plan gone miserably wrong with $100 million sitting in an account that I'm the custodian of.&#8221; He added that he never intended to personally profit from the funds.
Milei&nbsp;said&nbsp;that he never promoted the coin, and anyone who invested in the coin did so voluntarily. The president has faced calls for impeachment and criminal charges&nbsp;<a href="https://in.benzinga.com/25/02/43761407/argentinas-javier-milei-faces-impeachment-for-promoting-tainted-libra-memecoin-that-pumped-and-dumpedpresidents-office-orders-inquiry" target="_blank" rel="noreferrer noopener">against him</a>&nbsp;over the scandal.
Price Action: At the time of writing, LIBRA was exchanging hands at $0.06471, down 18.93% in the last 24 hours, <a href="https://coinmarketcap.com/currencies/libra-viva-la-libertad-project/#About">according</a> to&nbsp;CoinMarketCap.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/03/44268317/sec-postpones-approval-of-several-crypto-spot-etfs-says-influential-analyst">Dogecoin, XRP ETF Filings Delayed By SEC But Influential Analyst Says &#8216;Relatively High&#8217; Odds Of Approval</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Global

$SOL

LIBRA Token Fallout: Argentine Lawyer Demands Extradition Of Project Creator From US

Business Outlook
For the first quarter of 2025, UCLOUDLINK expects total revenues to be between US$18.2 million and US$19.5 million, representing an increase of 0.6% to 7.7% compared to the same period of 2024. For 2025, UCLOUDLINK expects total revenues to be between US$95.0 million and US$130.0 million, representing an increase of 3.7% to 41.9% from 2024.

UCLOUDLINK Outlook: For Q1 Expects Total Revenues Of $18.2M-$19.5M Vs. $24M Est.; For 2025 Expects Total Revenues Of $95M-$130M Vs. $104.5M Est.

Goldman Sachs analyst Duffy Fischer initiates coverage on Nutrien (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTR#NYSE">NTR</a>) with a Sell rating and announces Price Target of $53.

Goldman Sachs Initiates Coverage On Nutrien with Sell Rating, Announces Price Target of $53

Ucloudlink Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCL#NASDAQ">UCL</a>) reported quarterly earnings of $0.04 per share. This is a 20 percent decrease over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $26.00 million which beat the analyst consensus estimate of $25.15 million by 3.38 percent. This is a 19.65 percent increase over sales of $21.73 million the same period last year.

Earnings Beats

Ucloudlink Group Q4 2024 GAAP EPADS $0.04 Down From $0.05 YoY, Sales $26.00M Beat $25.15M Estimate

Goldman Sachs analyst Duffy Fischer initiates coverage on CF Industries Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CF#NYSE">CF</a>) with a Neutral rating and announces Price Target of $86.

Goldman Sachs Initiates Coverage On CF Industries Holdings with Neutral Rating, Announces Price Target of $86

Goldman Sachs analyst Duffy Fischer initiates coverage on Mosaic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOS#NYSE">MOS</a>) with a Buy rating and announces Price Target of $31.

Goldman Sachs Initiates Coverage On Mosaic with Buy Rating, Announces Price Target of $31

Goldman Sachs analyst Duffy Fischer initiates coverage on FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Buy rating and announces Price Target of $51.

Goldman Sachs Initiates Coverage On FMC with Buy Rating, Announces Price Target of $51

<a href="https://www.reuters.com/business/retail-consumer/us-food-giants-pepsico-conagra-seek-exempt-some-imports-tariffs-trade-group-says-2025-03-12/" title="https://www.reuters.com/business/retail-consumer/us-food-giants-pepsico-conagra-seek-exempt-some-imports-tariffs-trade-group-says-2025-03-12/">https://www.reuters.com/business/retail-consumer/us-food-giants-pepsico-conagra-seek-exempt-some-imports-tariffs-trade-group-says-2025-03-12/</a>

Reuters Reported Wednesday, PepsiCo, Conagra, J M Smucker Requested President Trump Exempt Ingredients Not Available From U.S. Sources, From Tariffs

Goldman Sachs analyst Duffy Fischer initiates coverage on Corteva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>) with a Buy rating and announces Price Target of $71.

CTVA

Goldman Sachs Initiates Coverage On Corteva with Buy Rating, Announces Price Target of $71

<a href="https://www.wsj.com/articles/sunnova-prepares-restructuring-talks-that-could-include-bankruptcy-filing-f0e3c7ce" title="https://www.wsj.com/articles/sunnova-prepares-restructuring-talks-that-could-include-bankruptcy-filing-f0e3c7ce">https://www.wsj.com/articles/sunnova-prepares-restructuring-talks-that-could-include-bankruptcy-filing-f0e3c7ce</a>

Legal

NOVA

The Wall Street Journal Reported Wednesday, Sunnova Energy Engaged JPMorgan to Share Financial Data With Creditors, Exploring Debt Restructuring That May Include Bankruptcy Filing

Alibaba Group Holding Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BABAF#OTC">BABAF</a>) has released a <a href="https://www.benzinga.com/markets/emerging-markets/25/03/44229408/alibaba-unveils-new-ai-chip-to-power-chinas-open-source-tech-push-challenge-us-chip-giants">new artificial intelligence model</a> that is capable of reading human emotions. The Chinese tech giant is escalating competition with&nbsp;OpenAI&nbsp;as it aggressively pushes into AI technologies following the&nbsp;DeepSeek&nbsp;AI saga in January. 
What Happened: Despite the launch, Alibaba&#8217;s shares dropped 2.45% to 131.50 HKD ($16.92) on the Hong Kong Exchange. 
The new open-source R1-Omni model, developed by Alibaba&#8217;s Tongyi Lab, can infer emotional states from video while describing people&#8217;s clothing and environment, <a href="https://www.bloomberg.com/news/articles/2025-03-12/alibaba-releases-emotional-intelligence-model-to-rival-chatgpt">reported</a> Bloomberg.
Alibaba&#8217;s R1-Omni is available for free on Hugging Face, unlike OpenAI&#8217;s GPT-4.5, which costs $200 per month.
The release comes as Alibaba Chairman Joe Tsai projected the AI market could reach $10 trillion, stating that AI could &#8220;enhance the quality of work by taking care of tedious research-related tasks&#8221; across industries including finance and law. Tsai anticipates that Alibaba will gain considerable <a href="https://in.benzinga.com/media/25/03/44274410/alibaba-chair-says-ai-total-addressable-market-is-10-trillion-expects-benefits-via-its-cloud-business">advantages from its cloud computing division</a>.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/25/03/44267663/ray-dalio-warns-us-debt-crisis-could-trigger-shocking-developments-calls-to-reduce-deficit-at-3-of-gdp" target="_blank" rel="noreferrer noopener">Ray Dalio Warns US Debt Crisis Could Trigger ‘Shocking Developments' Calls To Reduce Deficit At 3% Of GDP</a>
Why It Matters: Alibaba has committed $53 billion toward cloud and AI infrastructure over the next three years. The company recently launched QwQ-32B, a reasoning model claiming performance comparable to DeepSeek&#8217;s R1 <a href="https://in.benzinga.com/personal-finance/25/03/44281204/jack-ma-xi-jinping-and-the-53b-ai-bet-alibabas-comeback-signals-a-new-era-for-chinese-big-tech">despite having fewer parameters</a>.
Alibaba.com president&nbsp;Zhang Kuo&nbsp;aims for 100% AI tool adoption among the platform&#8217;s 200,000 merchants by the end of 2025, with over half <a href="https://www.benzinga.com/markets/25/03/44241563/alibabas-wholesale-marketplace-arm-sets-ambitious-goal-for-full-ai-adoption-by-merchants-in-2025">currently using these tools weekly</a>.
Analyst consensus gives Alibaba a <a href="https://www.benzinga.com/quote/BABA/analyst-ratings">price target</a> of $138.26, with recent ratings from Benchmark, Bernstein, and Morgan Stanley averaging $178.33, suggesting a potential 32.39% upside.
<figure class="wp-block-image aligncenter size-full is-resized"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13045827/Screenshot-2025-03-13-at-2.27.29%E2%80%AFPM.png" alt="" class="wp-image-822423" style="width:694px;height:auto" /></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44267822/palantir-executive-pushes-pentagon-to-adopt-software-first-approach-noting-us-allocates-less-than-1-of-defense-budget-to-modern-battlefield" target="_blank" rel="noreferrer noopener">Palantir Calls For ‘Software-First Approach' As Pentagon Spends Under 1% On Modern Warfare</a></li>
</ul>
Image Via Shutterstock

Equities

Tech

BABA

ALIBABA GROUP HOLDING LTD by Alibaba Group Holding Limited

BABAF

Alibaba Launches AI That Reads Emotions To Rival OpenAI, But Shares Falls On Hong Kong Exchange Despite Joe Tsai's $10 Trillion Market Outlook

B of A Securities analyst Vivek Arya upgrades Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) from Underperform to Neutral and raises the price target from $19 to $25.

Upgrades

INTC

B of A Securities Upgrades Intel to Neutral, Raises Price Target to $25

Small Cap

Opinion

Press Releases

Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment

Iambic Therapeutics Appoints Michael Secora, Ph.D. as Chief Corporate Development Officer and Chief Financial Officer

Recursion to Present at 43rd Annual JP Morgan Healthcare Conference

Recursion Announces Two Key Investigational Oncology Drugs Advancing to Clinical Trials, Targeting High Unmet Needs in Hematologic Malignancies, Small-Cell Lung Cancer, & More

Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028

Recursion Presents Phase 2 Data for REC-994 in CCM in Late-Breaking Oral Presentation at the International Stroke Conference

Health Care

Economics

Altitude Lab Startups Raise $154M in Capital

Altitude Lab Launches Pre-seed Venture Fund, Anchored by Recursion CEO Chris Gibson, Enabling SBIR-awarded Biotechs Hit by Funding Gap to Build in Salt Lake City

Comments

Recursion Pharmaceuticals

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO